New Treatments Have Changed the Game

• Autores: Shelley N. Facente, Katie Burk, Kelly Eagen, Elise S. Mara, Aaron A. Smith, Colleen S. Lynch
• Localización: Infectious disease clinics of North America, ISSN 0891-5520, Vol. 32, Nº. 2, 2018 (Ejemplar dedicado a: Overcoming Barriers to Eliminate Hepatitis C), págs. 313-322
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • In the pre–direct-acting antiviral era, hepatitis C virus (HCV) treatments were complex and largely managed by hepatologists, gastroenterologists, and infectious disease physicians. As direct-acting antivirals have driven up demand for treatment, the relative scarcity of these specialists has created a bottleneck effect, resulting in only a fraction of HCV-infected individuals offered treatment. The San Francisco Health Network is a safety net system of care. Its intervention was designed to be sustainable and scalable; with minimal time commitments for training providers, primary care–based HCV treatment increased 3-fold in a period of just over 3 years.